Adam Kibel, MD
Urology · Boston, MANPI 1285650580
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $69,293 of the $92,029 with a category attached, or 75.3%. It is spread thinly across 21 manufacturers, the largest accounting for just 19.5%. Reporting peaked in 2019 at $32,721 and has fallen 99.1% since, to $286 in 2025. Among urology clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 87 payments — averaging $1057.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$18K
- Janssen Research & Development, LLC$16K
- Janssen Scientific Affairs, LLC$12K
- E.r. Squibb & Sons, L.L.C.$12K
- Insightec,inc$8K
- GE HealthCare$4K
- plus $21K from 15 others
Across 3 payments — averaging $74,524 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$224K
What the payments were for
- Consulting fees$69,29375%
- Speaking & faculty fees$15,48017%
- Travel & lodging$4,7245%
- Food & beverage$2,5323%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 13 | $17,947 |
| Janssen Research & Development, LLC | 18 | $15,524 |
| Janssen Scientific Affairs, LLC | 15 | $12,431 |
| E.r. Squibb & Sons, L.L.C. | 13 | $12,375 |
| Insightec,inc | 4 | $7,881 |
| GE HealthCare | 2 | $4,400 |
| Myovant Sciences Inc. | 1 | $3,950 |
| Bayer | 2 | $3,444 |
| Pfizer | 2 | $2,092 |
| Blue Earth Diagnostics | 1 | $2,000 |
| Exelixis Inc. | 1 | $1,980 |
| Tolmar, Inc. | 1 | $1,800 |
| Insightec,ltd | 2 | $1,577 |
| Progenics Pharmaceuticals, Inc. | 1 | $1,350 |
| Janssen Global Services, LLC | 1 | $1,240 |
| Astrazeneca UK Limited | 1 | $1,074 |
| EDAP Technomed Inc | 3 | $513 |
| Johnson & Johnson | 3 | $289 |
| Astellas Pharma US Inc | 1 | $79 |
| Urogen Pharma, Inc. | 1 | $51 |
| Medtronic | 1 | $32 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$92,029 in reported general payments places this provider in the 95th percentile of 327 urology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urology in Boston
- Christopher CutieBoston$3.5M
- Brian EisnerBoston$424K
- Stephen DretlerBoston$298K
- Tony LuongoBoston$265K
- Ricardo MunarrizBoston$118K
- Mehrdad AlemozaffarBoston$95K
- Ruslan KoretsBoston$86K
- Adam FeldmanBoston$74K
- William BoysenBoston$56K
- Shahin TabatabaeiBoston$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.